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ABSTRACT: The gluconeogenic contribution to glucose production in livers isolated from rats fasted for 24 h was
determined by 13C-NMR isotopomer distribution analysis of secreted glucose enriched from 99% [13C]bicarbonate (n¼ 4)
and 99% [1-13C]lactate (n¼ 4). Experiments with 3% 2H2Owere also performed, allowing the gluconeogenic contribution to
be measured by the relative 2H enrichments at positions 5 and 2 of glucose. From 13C-NMR analyses, the contribution of
gluconeogenesis to glucose output was estimated to be 93 3% for [13C]bicarbonate perfusion and 91 3% for
[1-13C]lactate perfusion, in good agreement with the 2H-NMR analysis of the gluconeogenic contribution to glucose
production (100 1% and 99 1%, respectively) and consistent with the expected negligible contribution from glyco-
genolysis. These results indicate that 13C-NMR analysis of glucose 13C-isotopomer distribution from either [13C]bicarbonate
or [1-13C]lactate precursor provides realistic estimates of the gluconeogenic contribution to hepatic glucose output.
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INTRODUCTION
During fasting, hepatic glucose is produced by glycogen
hydrolysis and gluconeogenesis (GNG). Rates of hepatic
glucose synthesis from these sources are influenced by
nutritional, hormonal and disease states. Therefore,
measurement of these fluxes provides key insights into
relationships between glucose metabolism and whole-
body physiology and pathophysiology. Traditionally,
GNG has been measured by comparing the enrichment
or specific radioactivity of a representative precursor
substrate, such as alanine or lactate, with that of plasma
glucose after infusion of 13C- or 14C-labeled alanine or
lactate tracer. However, with this approach, three factors
reduce the precision of the measurement: (1) true hepatic
precursor enrichment is difficult to measure in situ; (2)
there is unspecified loss and dilution of the tracer by
exchange with Krebs cycle intermediates; (3) the
contributions of glycerol GNG and glycogenolysis to
glucose production (GP) cannot be resolved, as both
processes dilute the 13C enrichment or 14C specific
radioactivity of plasma glucose relative to that of the
precursor pool. Mass isotopomer distribution analysis
(MIDA) overcomes these limitations by relating the tracer
enrichment of plasma glucose to that of the immediate
triose phosphate precursors (1,2). As any dilution of the
tracer between triose phosphate and glucose can only
arise from unlabeled glucose generated by glycogenoly-
sis, the method provides a measurement of the total
GNG contribution to GP relative to glycogenolysis. The
measurement is also practical in that enrichment of triose
phosphate precursor is calculated from the isotopomer
distribution of plasma glucose, eliminating the need to
measure the enrichment of hepatic precursor pools. A key
assumption of MIDA is that the tracer has equal access to
all hepatic GNG activity. One of the conditions is that the
tracer arteriovenous concentration gradient across the
hepatic lobule must be relatively small so that periportal
and perivenous hepatocytes have equal access to the
tracer. This applies for some substrates such as lactate, but
not for other GNG precursors that are quantitatively
extracted from the circulation by the liver, such as
glycerol (3,4). The resulting concentration gradient of
glycerol across the hepatic lobule means that periportal
cells experience higher tracer concentrations than
perivenous cells. Consequently, the [13C]isotopomer
distribution of glucose obtained from [13C]glycerol is
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weighted towards the relatively high local enrichment of
the periportal triose phosphate pool. This leads to an
overestimate of hepatic triose phosphate 13C enrichment
and a corresponding underestimation of the fraction of GP
derived from GNG. Thus, under starvation conditions in
which hepatic glycogen is depleted and GNG is expected
to contribute 100% of GP, MIDA with either [2-13C]
glycerol or [U-13C]glycerol gave improbably low esti-
mates of the GNG fraction (5). To date, there have been no
reported studies of alternative GNG tracers that are more
evenly distributed across the hepatic lobule and might
therefore provide more valid estimates of GNG byMIDA.
We reasoned that [13C]bicarbonate might be an effec-
tive tracer for quantification of GNG by isotopomer dis-
tribution analysis because its hepatic arteriovenous
concentration gradient is small and its concentration is
not a limiting factor for carboxylation reactions anywhere
in the liver. As with [14C]bicarbonate (6), incorporation
of [13C]bicarbonate into glucose requires the carboxy-
lation of an anaplerotic substrate such as pyruvate to
form [1-13C]oxaloacetate. Exchange of oxaloacetate with
malate and fumarate results in an approximately equal
distribution of 13C enrichment in [1-13C]oxaloacetate and
[4-13C]oxaloacetate. GNG utilization of [4-13C]oxaloace-
tate via phosphoenolpyruvate carboxykinase results in
the formation of [1-13C]phosphoenolpyruvate (PEP) and
subsequent [1-13C]triose phosphates. Glucose is formed
from two triose phosphate units, and the probability of
generating [3,4-13C2]glucose is a function of the enrich-
ment of the precursor [1-13C]triose phosphate (Fig. 1).
The glucose isotopomer populations can be quantified
directly by 13C-NMR spectroscopy because [3,4-13C2]
glucose generates doublet signals as a result of 13C–
13C coupling that are resolved from the singlet resonances
of [3-13C]glucose and [4-13C]glucose. The fractional
enrichment of the triose phosphate precursor pool is
directly obtained from the ratio of the doublet to singlet
signals, as shown in Fig. 1. As only C3 and C4 of glucose
are enriched from [13C]bicarbonate, the other 13C signals
of glucose represent background natural abundance (NA)
at 1.1%, and, as such, they provide convenient internal
standards for estimating excess 13C enrichment in C3 and
C4 of glucose. Thus, by comparing the actual glucose
enrichment with that of the triose phosphate precursor
derived by isotopomer distribution analysis, the fraction
of glucose derived from triose phosphate (assumed to be
equal to the fraction derived by GNG) can be estimated.
[Glycogen conversion into glucose is assumed to occur
entirely via the direct pathway (glycogen!Glc1P!
Glc6P! glucose). Any glycogen that is converted into
C3 compounds before Glc6P and glucose will be counted
as GNG.] [1-13C]Lactate is converted into [4-13C]oxaloa-
cetate via lactate dehydrogenase and pyruvate carboxy-
lase, therefore it provides the same gluconeogenic
precursor enrichment pattern as [13C]bicarbonate.
In this report, we show that estimates of [1-13C]triose
precursor enrichment using the isotopomer distribution
analysis of Neese et al. (2) can be simply and directly
obtained by 13C-NMR spectroscopy of the monoacetone
derivative of glucose (MAG), as shown schematically in
Figure 1. Glucose 13C isotopomer distribution from triose phosphate (Triose-P) and
corresponding simulated NMR spectrum. Glucose labeled in only one position (C3 or
C4) is represented by a single signal (S) in the NMR spectrum. Glucose labeled in both
carbons produces a doublet signal (D) because of the 13C3–13C4 coupling. The
symbol x represents the probability of the pool of triose phosphate being labeled with
13C in C1.
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Fig. 1. To determine if this approach provides realistic
estimates of the GNG contribution to GP, we applied
the method to perfused livers obtained from rats fasted
for 24 h, in which the contribution of GNG to GP is
expected to approach 100%. We compared this method
with the 2H2O measurement of fractional GNG based on
the 2H-enrichment ratio in positions 5 and 2 of glucose
(H5/H2). In either perfused or in situ livers depleted of
glycogen, the H5/H2 ratio provides realistic estimates of
the fraction of GP derived from GNG (i.e. approaching
100% contribution). This ratio can be derived by 2H-
NMR spectroscopy of the MAG derivative without inter-
ference from the 13C-enrichment distributions (7–11).
Likewise, the [13C]isotopomer analysis is not modified by
the presence of 2–3% 2H enrichment, therefore the
deuterated water and 13C-labeled tracer can be adminis-
tered at the same time.
MATERIALS AND METHODS
Materials
13C-enriched compounds (sodium [13C]bicarbonate and
sodium [1-13C]lactate) and 2H2O were purchased from
Cambridge Isotope Laboratories (Cambridge, MA, USA)
and Eurisotop (Saint-Aubin, France), respectively. Other
materials were analytical grade and used without further
purification (Sigma, St Louis, MO, USA).
Experimental design
Healthy male Wistar Han rats, 12 weeks old, were
purchased from Charles River Laboratories, Barcelona,
Spain. After being starved for 24 h, the animals were
randomly divided into two groups. Before liver removal,
each animal was anesthetized with an intraperitoneal
injection of ketamine (200mL/100 g body weight). Then,
with the portal vein cannulated, each liver was perfused
(>20mL/min for 10min) with Krebs-Henseleit bicarbon-
ate/H2O buffer bubbled continuously with a 95%/5%
mixture of O2/CO2 at 378C. After this wash-out period,
the livers of one group were perfused (>20mL/min
for 20min) with Krebs-Henseleit [13C]bicarbonate/3%
2H2O buffer supplemented with 1.0mM lactate, 0.1mM
pyruvate and 0.2mMoctanoate, and the livers of the second
group were perfused with Krebs-Henseleit bicarbonate/3%
2H2O buffer supplemented with 1.0mM [1-
13C]lactate,
0.1mM pyruvate and 0.2mM octanoate.
The perfusates obtained were lyophilized, and all the
glucose present in the extracts was converted into MAG
as described by Snowden (12). The lyophilized extracts
were treated with excess anhydrous deuterated acetone
and concentrated H2SO4 (4%, v/v) and stirred for 4 h.
Water was then added to the reaction mixture, and the
sample was neutralized with 2MNaOH. The pHwas then
adjusted to 2.0 with dilute HCl, and the solution was kept
for 5 h at 408C. The reaction was stopped by elevating the
pH to 8–9 with 2M NaOH, and the solvent was removed
by rotary evaporation. MAG was extracted from the dried
residue with a few milliliters of boiling ethyl acetate, and
the residue of the new extraction was dissolved in 600mL
90% acetonitrile/10% water.
NMR analysis
NMR spectra were acquired using a 5mm broadband
probe on a 11.7 T Varian Unity spectrometer (Varian
Instruments, Palo Alto, CA, USA) at 508C. Proton-
decoupled 13C-NMR spectra of liver and perfusate
samples were acquired using a 458 pulse, a 1.5 s acquisi-
tion time, and an interpulse delay of 3 s. Proton-decoupled
2H NMR spectra of the perfusate samples were obtained
in the unlockedmode using a 908 pulse, a 1.5 s acquisition
time, and no interpulse delay. Deconvolution and quanti-
fication of 13C and 2H NMR signals were performed with
the curve-fitting routine supplied with the NUTSTM
PC-based NMR spectral analysis program (Acorn NMR,
Inc., Fremont, CA, USA).
Contribution of GNG to hepatic GP by
isotopomer distribution analysis of glucose
enrichment from 13C-labeled tracers
The percentage 13C enrichment of glucose in C3 and C4
(Glc3F, Glc4F) was determined by the ratio of the total C3
or C4 signal relative to the neighboring NA C2 or C5
signals multiplied by 100. Excess 13C enrichment in C3
and C4 was determined by subtracting 1.1% from Glc3F
and Glc4F.
Triose phosphate precursor enrichment, xn, was
estimated from the C3 multiplet (x3) and C4 (x4) multiplet
by the following equations:
x3 ¼ C3D34=ðC3Sþ C3D34Þ (1)
x4 ¼ C4D34=ðC4Sþ C4D34Þ (2)
where C3S and C4S are the relative areas of the C3 and
C4 singlet signals after subtraction of NA contributions,
and C3D34 and C4D34 are the relative areas of the C3 and
C4 doublet signals.
The percentage of glucose derived from GNG was
calculated from the triose phosphate and glucose
enrichments of C3 and C4 as follows:
Percentage glucose from GNG; C3 analysis
¼ 100 Glc3F=x3 (3)
Percentage glucose from GNG; C4 analysis
¼ 100 Glc4F=x4 (4)
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From the 2H NMR spectra of MAG, the percentage
contribution of glycogenolysis and GNG was evaluated
by the ratio of deuterium signal intensities of positions
2 and 5 according to the following equation [7]:
Glycogenolysis contribution to GP :
½1 ðsignal 5=signal 2Þ  100 (5)
GNG contribution to GP :
ðsignal 5=signal 2Þ  100 (6)
Data presentation and statistical analysis
The results are presented as mean SE. A statistical
analysis was performed using theMann-Whitney U test, a
non-parametric alternative to the t test for independent
samples. In this test, two populations are considered
statistically different if UcalcUtable.
RESULTS
Glucose enrichment from [13C]bicarbonate
and [1-13C]lactate assessed by 13C NMR
The MAG derivative generates narrow and well-resolved
13C-NMR signals for all hexose carbons (10,13,14).
Representative 13C-NMR spectra derived from the
[13C]bicarbonate/2H2O and [1-
13C]lactate/2H2O labeling
experiments are represented in Fig. 2. As expected, the
two spectra are very similar as, with both tracers, position
1 of PEP and positions 3 and 4 of glucose are enriched
with 13C. In addition, the 13C-NMR signals are not
significantly perturbed by the low 2H-enrichment level
of glucose (3%). (Substitution of 1H by 2H results
in additional splitting of directly bound 13C via 13C–
2H coupling as well as an isotope shift for both directly
bound and neighboring 13C nuclei. With methine
functionalities, the directly bound 13C has no nuclear
Overhauser enhancement and its T1 is increased.) The
signals of C1, C2, C5 and C6 are derived from NA
13C and represent 1.1% enrichment. The signals of C3
and C4 are more intense and reflect enrichment from
the GNG incorporation of [13C]bicarbonate. The total
13C enrichment of C3 tended to be higher than that of
C4 (Table 1), indicating that 13C enrichment was not
completely equilibrated between glyceraldehyde 3-phos-
phate and dihydroxyacetone phosphate precursor pools
(Ucalc<Utable). In both experiments, C3 and C4 reson-
ances can be resolved into singlet and doublet com-
ponents, the doublet representing the [3,4-13C2]glucose
isotopomer (Fig. 2). After subtraction of the NA
contribution from the singlet signal, the ratio between
the doublet and the total (singlet and correspondent
doublet) provides the enrichment of the triose phosphate
precursor pool (Fig. 1 and Table 1). [1-13C]Lactate and
[13C]bicarbonate substrates enriched the triose phosphate
precursor pool to similar levels (Ucalc<Utable). Also, for
both tracers, the 13C enrichment of glucose was only
marginally less than that of the triose phosphate pool,
indicating that GNG accounted for almost all hepatic GP.
This was an expected result because, after 24 h of fasting,
almost all glycogen is depleted.
Glucose enrichment from
2H2O assessed by
2H NMR
On conversion to MAG, the 2H-NMR signals of glucose
are well resolved allowing precise quantification of their
relative intensities. These values are directly proportional
to the relative 2H enrichments in the respective sites of
glucose, and the fraction of glucose derived from GNG is
equal to the intensity of signal 5 relative to that of signal 2.
As shown in Fig. 3, the intensity of signal 5 approached
that of H2, indicating that GNG was the principal source
of GP: 100 1% and 99 1% for the perfusion with
[13C]bicarbonate/2H2O and [1-
13C]lactate/2H2O, respec-
tively (Figure 4). These data are consistent with the above
considerations on fasting glycogen effects and fractional
GNG estimates derived from the [13C]bicarbonate and
[1-13C]lactate isotopomer distribution measurements.
Enrichment of both H6 sites was significantly lower
than that of H2 (Ucalc>Utable) as seen by the difference
in the two signal intensities: the ratio H6S/H2 is equal
to 44 2% for [1-13C]lactate and 65 4% for
[13C]bicarbonate.
DISCUSSION
Glucose enrichment analysis by
13C and 2H NMR
Several tracer methods exist for quantifying the con-
tribution of GNG to hepatic GP. Determination of enrich-
ment of the immediate precursor by MIDA circumvents
many of the traditional limitations of carbon tracer
measurements as discussed in the introduction. The
[13C]bicarbonate tracer is evenly distributed throughout
the liver, therefore the observed 13C-enrichment distri-
bution of glucose represents all hepatic GNG activity
involving carboxylation reactions of the Krebs cycle.
With sufficient sample mass, the 13C-NMR method can
quantify very low excess 13C-enrichment levels of
[3,4-13C2]glucose (13), the product generated from the
GNG condensation of two 13C-enriched triose phosphate
molecules. This capability is an important consideration
in the MIDA approach because the enrichment level of
[3,4-13C2]glucose cannot exceed the square of the
enrichment of the triose phosphate precursor pool.
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Figure 2. Proton-decoupled 13C-NMR spectrum of MAG derived from perfusate glucose of rats infused with (a)
[13C]bicarbonate/2H2O and (b) [1-
13C]lactate/2H2O. The six carbons of the glucose skeleton (C1–C6) and an
expansion of the signals of C3 and C4 resonances resulting from the incorporation of [13C]bicarbonate are shown.
In each expansion, both the singlet (S) and the doublet (C3D34 and C4D34) signals can be resolved.
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Triose phosphate enrichment from [1-13C]lactate was
found to be 25%. Given a mixture of 99% 1mM
[1-13C]lactate and 0.1mM unlabeled pyruvate, the
pyruvate pool should be 90% enriched. After carbox-
ylation to oxaloacetic acid and randomization of
13C between C4 and C1, enrichment at each carbon will
be reduced by a factor of 2 to 45%. Assuming that net
anaplerosis is about twice that of the Krebs cycle flux
(15), the oxaloacetic acid carboxyls will be further diluted
by about two-thirds from the entry of unlabeled carbons
derived from acetyl-CoA, resulting in a an enrichment
of 30%. Recycling of PEP via pyruvate provides
additional opportunity for exchange of labeled 13C with
unlabeled CO2, thereby reducing the
13C enrichment of
oxaloacetic acid carboxyls (19). Therefore, the observed
triose phosphate enrichment of 25% can be explained
entirely by exchanges and dilutions at the Krebs cycle
level. When these considerations are applied to the
[13C]bicarbonate label, we reach a different conclusion.
Pyruvate carboxylation and randomization of oxaloace-
tic acid carbons will reduce the 13C-labeled precursor
enrichment to 50%, and dilution from acetyl-CoA will
further reduce this to33%. However, in this experiment,
PEP recycling will increase the 13C enrichment of oxa-
loacetic acid by providing additional opportunity for
entry of [13C]bicarbonate via carboxylation. Hence, the
triose phosphate enrichment would be expected to be
at least 33%, substantially higher than the 20% enrichment
that was measured. The most reasonable explanation for
this discrepancy is that the [13C]bicarbonate precursor
was diluted by exchange with unlabeled CO2 from the
carbogen gas used to maintain oxygenation and pH of
the perfusion fluid.
In the 2H2O measurement, the ratio of H5/H2
enrichment approached unity, indicating that all GP
was from GNG. H6/H2 ratios were significantly less,
indicating that there was a substantial contribution of
GNG from glycerol, an incomplete exchange between
the precursor hydrogens and perfusion water, or most
probably an incomplete backward scrambling between
malate and fumarate. The H6 pair of glucose are derived
from the methylene hydrogens of PEP and oxaloacetic
acid and the methyl hydrogens of pyruvate. Unlike H5,
which is enriched via the obligatory addition of water
hydrogen via enolase or triose phosphate isomerase,
2H incorporation into the H6 positions is contingent on
exchanges at the level of the Krebs cycle and pyruvate. To
the extent that these exchanges are incomplete, glucose
H6 enrichment will be less than that of H5.
Sensitivity and practicality of 13C NMR
isotopomer distribution analysis in humans
After overnight fasting, when GNG accounts for50% of
GP, a 4% enrichment of the triose phosphate precursor
pool would result in a steady-state [3,4-13C2]glucoseT
a
b
le
1
.
1
3
C
e
n
ri
ch
m
e
n
t
o
f
g
lu
co
se
m
e
a
su
re
d
d
ir
e
ct
ly
b
y
1
3
C
N
M
R
,c
a
lc
u
la
te
d
tr
io
se
p
h
o
sp
h
a
te
1
3
C
e
n
ri
ch
m
e
n
t
b
y
1
3
C
N
M
R
is
o
to
p
o
m
e
r
d
is
tr
ib
u
ti
o
n
a
n
a
ly
si
s,
a
n
d
th
e
co
n
tr
ib
u
ti
o
n
o
f
tr
io
se
p
h
o
sp
h
a
te
to
G
P
fr
o
m
th
e
[1
-1
3
C
]l
a
ct
a
te
a
n
d
[1
3
C
]b
ic
a
rb
o
n
a
te
p
e
rf
u
si
o
n
e
x
p
e
ri
m
e
n
ts
.
V
a
lu
e
s
a
re
m
e
a
n

S
E
[1
-1
3
C
]L
ac
ta
te
[1
3
C
]B
ic
ar
b
o
n
at
e
G
lu
co
se
1
3
C
en
ri
ch
m
en
t
(%
)
T
ri
o
se
p
h
o
sp
h
at
e
1
3
C
en
ri
ch
m
en
t
(%
)
T
ri
o
se
p
h
o
sp
h
at
e
co
n
tr
ib
u
ti
o
n
to
G
P
(%
)
G
lu
co
se
1
3
C
en
ri
ch
m
en
t
(%
)
T
ri
o
se
p
h
o
sp
h
at
e
1
3
C
en
ri
ch
m
en
t
(%
)
T
ri
o
se
p
h
o
sp
h
at
e
co
n
tr
ib
u
ti
o
n
to
G
P
(%
)
C
ar
b
o
n
3
2
5

2
2
2

2
9
0

4
2
1

1
2
0

1
9
5

4
C
ar
b
o
n
4
2
8

1
2
6

0
9
2

2
1
9

1
1
7

1
9
1

2
Copyright # 2007 John Wiley & Sons, Ltd. NMR Biomed. 2008; 21: 337–344
DOI: 10.1002/nbm
342 T. C. ALVES ET AL.
abundance of 0.16% and excess 13C enrichment of
about 2% in C3 and C4. As demonstrated by Jin et al.
(13), quantifiable doublet signals from 22mmol MAG
with 0.34% abundance of [3,4-13C2]glucose were
obtained with less than 2 h of NMR collection time.
Excess enrichment levels of 2% in C3 and C4 can be
precisely quantified if the NA signals of the other carbons
have acceptable signal-to-noise ratios. In humans, hepatic
Glc6P can be non-invasively sampled by glucuronidation
probes such as paracetamol and menthol (10,16), and
this approach has two key advantages for quantifying
enrichment fromGNG tracers compared with the analysis
of plasma glucose. First, glucuronides provide higher
amounts of analyte (>100mmol) than a 20–30mL blood
collection. Second, the relatively small hepatic sugar
phosphate pool sizes ensure that isotopic steady-state
fromGNG 13C-labeled precursors is rapidly achieved.We
think that the predicted 3,4-hexose 13C-enrichment levels
of 0.16% should be quantifiable from a urine glucuronide
sample with reasonably short collection times (1–2 h)
either by direct-detect 13C NMR or by more sensitive
indirect detection methods such as J-resolved hetero-
nuclear single-quantum coherence spectroscopy (17).
Given the dilutions at the Krebs cycle level (6), a 4%
enrichment of [1-13C]triose phosphates would require a
bicarbonate precursor pool 13C enrichment of 8%. In
the study of Allsop et al. (18), a steady-state plasma
bicarbonate enrichment of0.08% was achieved in 2 h in
75 kg humans by administering a prime of 0.38mmol
sodium [13C]bicarbonate followed by a constant infus-
ion of 0.3mmol/h. The total amount of sodium [13C]
bicarbonate administered was therefore1mmol. On this
basis, 8% 13C enrichment of plasma bicarbonate would
require about 100mmol (8.5 g) sodium [13C]bicarbonate
tracer. This quantity is comparable to the amounts of
[1-13C]acetate or [2-13C]glycerol used in human MIDA
studies of lipogenesis and GNG (19,20,21).
In conclusion, we studied the use of [13C]bicarbonate and
[1-13C]lactate substrates and a simple 13CNMR isotopomer
analysis for quantification of the fraction of hepatic glucose
derived from GNG. The method used to measure GNGwas
based on the 13C enrichment of the immediate glucose
precursor which overcomes the limitations of the usual
methodologies. The results from 13C and 2H analysis were
similar, thus validating the method.
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